Table 1.
Before Care Pathway (n = 752 patients) | After Care Pathway (n = 749 patients) | p-value | |
---|---|---|---|
Age, median (IQR) | 67 (59–74) | 67 (58–75) | 0.89 |
Female, no. (%) | 399 (53) | 380 (51) | 0.37 |
Race, no. (%) | 0.365 | ||
White | 470 (63) | 456 (61) | |
Black | 49 (6.5) | 49 (6.5) | |
Asian / Pacific Islander | 129 (17) | 130 (17) | |
Other / Unknown | 104 (14) | 114 (15) | |
Hispanic | 70 (9.3) | 61 (8.1) | 0.027 |
Modified Charlson comorbidity score, median (IQR) | 4 (2–5) | 4 (2–5) | 0.22 |
Prior cognitive impairment, no. (%) | 119 (16) | 115 (15) | 0.80 |
Primary Hospital Service, no. (%) | 0.64 | ||
Neurology | 163 (22) | 168 (22) | |
Neurosurgery | 359 (48) | 365 (49) | |
Hospital medicine | 137 (18) | 138 (18) | |
Other | 93 (12) | 78 (10) |
mCCM modified Charlson comorbidity score